1. To establish a network for cellular and subcellular study of kidney stone disease.
2. To apply advanced biotechnology (e.g. proteomics, mass spectrometry, laser-scanning confocal microscopy, fluorescence imaging, flow cytometry, scanning electron microscopy, transmission electron microscopy) to address pathogenic mechanisms that calcium oxalate (CaOx) crystals play in kidney stone disease.
3. To offer training opportunities on proteomics and molecular cell biology for PhD and MSc students.
